Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Agilent Technologies (NY:A)

121.38 +0.72 (+0.60%)
Official Closing Price Updated: 5:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Agilent Technologies

< Previous 1 2 3 4 5 6 7 8 9 Next >
Agilent Showcases Comprehensive Cancer Portfolio Solutions at AACR 2023
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces NGS Assay for Comprehensive Genomic Profiling (CGP) for Advancing Precision Oncology
From Agilent Technologies Inc.
Via Business Wire
Agilent and PathAI Partner to Deliver AI-Powered Assay Development Solutions for Biopharma Research and Clinical Applications
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces High-Performance Cary 3500 Flexible UV-Vis System
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Thought Leader Award to Dr. Chenli Liu
From Agilent Technologies Inc.
Via Business Wire
Agilent Presents 2023 Darlene Solomon Award to Victor Chang Cardiac Research Institute Scientist, Kathryn Wolhuter
From Agilent Technologies Inc.
Via Business Wire
Agilent Announced as Instrument Business Outlook 2022 Company of the Year
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces End-to-End Digital Pathology Workflow Solution at USCAP 2023
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu
From Agilent Technologies Inc.
Via Business Wire
Agilent Again Named One of Barron’s 100 Most Sustainable Companies
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Acquisition of e-MSion, Early-Stage Company Behind ECD Technology that Helps Accelerate Drug Development
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Global Distribution Agreement with Proscia to Accelerate Data-Driven Precision Medicine
From Agilent Technologies Inc.
Via Business Wire
Agilent to Present at Barclays Global Healthcare Conference
From Agilent Technologies Inc.
Via Business Wire
Agilent Reports First-Quarter Fiscal Year 2023 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Bravo NGS Automated Liquid Handling Platform with On-Deck Thermal Cycler
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Cell Analysis Workflow Automation for Immuno-Oncology, Virology, and Vaccine Development Markets
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Cash Dividend of 22.5 Cents Per Share
From Agilent Technologies Inc.
Via Business Wire
Agilent Inspires at SLAS2023, Highlighting Innovative Automated Workflow Solutions
From Agilent Technologies Inc.
Via Business Wire
Colorado Governor Polis Helps Agilent Break Ground on $725 Million Expansion of Manufacturing Operations in Frederick
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces New NovoCyte Flow Cytometer System Software for 21 CFR Part 11 Compliance
From Agilent Technologies Inc.
Via Business Wire
Agilent to Announce First-Quarter Fiscal Year 2023 Financial Results Feb. 28
From Agilent Technologies Inc.
Via Business Wire
Agilent to Collaborate with Quest Diagnostics to Extend Access to the Agilent Resolution ctDx FIRST Liquid Biopsy Test
From Agilent Technologies Inc.
Via Business Wire
Agilent Included in Just Capital’s 2023 List of Most Just Companies
From Agilent Technologies Inc.
Via Business Wire
Agilent Authorizes $2 Billion Share Repurchase Program
From Agilent Technologies Inc.
Via Business Wire
Agilent Investing $725 Million to Expand State-of-the-Art Manufacturing Capacity for Production of Nucleic Acid-Based Therapeutics
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
From Agilent Technologies Inc.
Via Business Wire
Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications
From Agilent Technologies Inc.
Via Business Wire
Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
From Agilent Technologies Inc.
Via Business Wire
Agilent Resolution ctDx FIRST Receives FDA Approval as a Liquid Biopsy Companion Diagnostic Test for Advanced Non-small Cell Lung Cancer
From Agilent Technologies Inc.
Via Business Wire
Agilent Again Named to Newsweek’s List of America’s Most Responsible Companies
From Agilent Technologies Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.